Fox Chase Cancer Center Welcomes Dr. Teresa Y. Lee

September 20, 2021

PHILADELPHIA (September 20, 2021) – Fox Chase Cancer Center is pleased to announce the hiring of Teresa Y. Lee, MD, PhD, as an assistant professor. Lee will focus on sarcoma and head and neck cancer.

Lee will begin her tenure at Fox Chase on September 20 following her completion of the Hematology/Oncology Fellowship at Thomas Jefferson University Hospital, where she also completed her residency in internal medicine. She was named a chief hematology/oncology fellow in 2020.

During her residency, she received the Thomas Jefferson University Hospital Professionalism Award in 2015 and 2016 and the Thomas Jefferson University Hospital Resident Award in Patient Satisfaction. She also led the Outpatient Quality Improvement Project, which aimed to improve arrival rates at the Jefferson Hospital Ambulatory Practice.

She received her MD and a doctorate in microbiology and immunology from the University of Maryland. While working towards her degrees from the university, she was elected to the Alpha Omega Alpha honor society and received an NIH T32 Training Grant for her dissertation research on microRNA. Her research led to a US provisional patent for methods for reducing tumorigenesis by inhibiting human RNase-L.

Lee has been an invited lecturer for an advanced immunology course and a graduate immunobiology course at the University of Maryland.

Lee attended Harvard University on an academic scholarship and graduated cum laude with a bachelor’s degree in biology.

She is a member of the American College of Physicians, the American Society of Hematology, and the American Society of Clinical Oncology. Lee speaks Mandarin and has outside interests in scuba diving, children’s books, and gardening.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.


For more information, call 888-369-2427

Connect with Fox Chase